Form D · Hospitals and Physicians
Arkson Nutraceuticals Corp.
Bellaire, TX · CIK 0001389413
Offering snapshot reported Feb 1, 2011 · SEC filing
- Reported sold
- $0 Offering amount: $1
- Investors reported
- 80 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 1, 2011 | Initial | $0 | No comparison | 80 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-154676
The shares were issued in connection with the tax free contribution of First Surgical Texas Inc. into the Issuer. No cash consideration was paid in connection with the contribution.
Source: Form D, filed Feb 1, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony Rotondo | Director, Executive |
| David Tomaszek | Director |
| Jacob Varon | Director |
Issuer details
Industry: Hospitals and Physicians (See others in industry)
Address:
C/O First Surgical Partners, L.L.C. 411 First Street
Bellaire, TX, 77401
Bellaire, TX, 77401